PSYC.CNPsyched Wellness Ltd.
The schedule
- Thu22Oct
Psyched Wellness reports fiscal Q2 results, with market focus on maintaining its 201% YoY revenue growth from recent functional mushroom product expansions.
- Fri20Nov
Expected timeline for a mandatory capital raise given the company's sub-$1M cash balance and consistent operational cash burn.
- Wed27Jan
Fiscal Q3 update to evaluate holiday quarter sales momentum for the Amanita Muscaria consumer packaged goods.
- Wed26May
Full-year results and strategic outlook for FY 2027 operating under President Trump's evolving FDA consumer health framework.
Past
- Wed12Aug
Actual outcome: Bull
PSYC.CN surged over 100% following a strong earnings report that exceeded expectations, showcasing robust revenue growth and improved margins. The results signaled a turnaround in operational performance and renewed investor confidence in the company's strategic direction. [Market retrospective · Ultra-Short (1–5 days)] Missed anticipation: +100.0% from 2026-08-12 to 2026-08-17 (~5.1σ vs typical 1d vol). Target evaluation date 2026-08-18 (not yet reached as of 2026-08-17). Confidence 95%. [Market retrospective · Ultra-Short (1–5 days)] Updated observation 2026-08-18: +100.0% from 2026-08-12 (~5.1σ). Target date 2026-08-18 reached; move through 2026-08-18 observed. [Market retrospective · Ultra-Short (1–5 days)] Updated observation 2026-08-20: +100.0% from 2026-08-12 (~5.1σ). Target date 2026-08-18 reached; move through 2026-08-20 observed. [Market retrospective · Ultra-Short (1–5 days)] Updated observation 2026-08-24: +100.0% from 2026-08-12 (~5.1σ). Target date 2026-08-18 reached; move through 2026-08-24 observed. [Market retrospective · Ultra-Short (1–5 days)] Updated observation 2026-09-07: +100.0% from 2026-08-12 (~5.1σ). Target date 2026-08-18 reached; move through 2026-09-07 observed. [Market retrospective · Ultra-Short (1–5 days)] Updated observation 2026-09-08: +100.0% from 2026-08-12 (~5.1σ). Target date 2026-08-18 reached; move through 2026-09-08 observed. [Market retrospective · Ultra-Short (1–5 days)] Updated observation 2026-09-08: +100.0% from 2026-08-12 (~5.1σ). Target date 2026-08-18 reached; move through 2026-09-08 observed. [Market retrospective · Ultra-Short (1–5 days)] Updated observation 2026-09-09: +100.0% from 2026-08-12 (~5.1σ). Target date 2026-08-18 reached; move through 2026-09-09 observed. [Market retrospective · Ultra-Short (1–5 days)] Updated observation 2026-09-10: +100.0% from 2026-08-12 (~5.1σ). Target date 2026-08-18 reached; move through 2026-09-10 observed. [Market retrospective · Ultra-Short (1–5 days)] Updated observation 2026-09-10: +100.0% from 2026-08-12 (~5.1σ). Target date 2026-08-18 reached; move through 2026-09-10 observed. [Market retrospective · Ultra-Short (1–5 days)] Updated observation 2026-09-14: +100.0% from 2026-08-12 (~5.1σ). Target date 2026-08-18 reached; move through 2026-09-14 observed.
PSYC.CN surged over 100% following a strong earnings report that exceeded expectations, showcasing robust revenue growth and improved margins. The results signaled a turnaround in operational performance and renewed investor confidence in the company's strategic direction. [Market retrospective · Ultra-Short (1–5 days)] Missed anticipation: +100.0% from 2026-08-12 to 2026-08-17 (~5.1σ vs typical 1d vol). Target evaluation date 2026-08-18 (not yet reached as of 2026-08-17). Confidence 95%. [Market retrospective · Ultra-Short (1–5 days)] Updated observation 2026-08-18: +100.0% from 2026-08-12 (~5.1σ). Target date 2026-08-18 reached; move through 2026-08-18 observed. [Market retrospective · Ultra-Short (1–5 days)] Updated observation 2026-08-20: +100.0% from 2026-08-12 (~5.1σ). Target date 2026-08-18 reached; move through 2026-08-20 observed. [Market retrospective · Ultra-Short (1–5 days)] Updated observation 2026-08-24: +100.0% from 2026-08-12 (~5.1σ). Target date 2026-08-18 reached; move through 2026-08-24 observed. [Market retrospective · Ultra-Short (1–5 days)] Updated observation 2026-09-07: +100.0% from 2026-08-12 (~5.1σ). Target date 2026-08-18 reached; move through 2026-09-07 observed. [Market retrospective · Ultra-Short (1–5 days)] Updated observation 2026-09-08: +100.0% from 2026-08-12 (~5.1σ). Target date 2026-08-18 reached; move through 2026-09-08 observed. [Market retrospective · Ultra-Short (1–5 days)] Updated observation 2026-09-08: +100.0% from 2026-08-12 (~5.1σ). Target date 2026-08-18 reached; move through 2026-09-08 observed. [Market retrospective · Ultra-Short (1–5 days)] Updated observation 2026-09-09: +100.0% from 2026-08-12 (~5.1σ). Target date 2026-08-18 reached; move through 2026-09-09 observed. [Market retrospective · Ultra-Short (1–5 days)] Updated observation 2026-09-10: +100.0% from 2026-08-12 (~5.1σ). Target date 2026-08-18 reached; move through 2026-09-10 observed. [Market retrospective · Ultra-Short (1–5 days)] Updated observation 2026-09-10: +100.0% from 2026-08-12 (~5.1σ). Target date 2026-08-18 reached; move through 2026-09-10 observed. [Market retrospective · Ultra-Short (1–5 days)] Updated observation 2026-09-14: +100.0% from 2026-08-12 (~5.1σ). Target date 2026-08-18 reached; move through 2026-09-14 observed.